Genome International India Private Limited, a active private limited company, was established on 09 July 2004 in Chennai, Tamil Nadu, India. Engaging in application development & software solutions within the information technology sector, it holds CIN: U73100TN2004PTC053684. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹0.10 M.
Formerly known as Genome International Private Limited, Genome International India Private Limited. It upholds a compliant status. Employing 30 professional, Its leadership includes Periannan Senapathy (Director), Abarajeetha Rajendran (Director). Past directors included Roopamala Senapathy, Abarajeetha Rajendran, Kalpana Mandradiar. Its latest AGM occurred on 31 December 2024, with the balance sheet filed on 31 March 2024. It is based at 383, I Cross Street, Nehru Nagar Old Mahabalipuram Road, Kottivakkam, Chennai, Tamil Nadu, 600096.
U73100TN2004PTC053684
053684
09 July 2004
₹2.00 Cr
₹0.10 M
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Genome International India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Periannan Senapathy | Director | 09 Jul 2004 | Current |
| Abarajeetha Rajendran | Director | 09 Aug 2023 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Oct 2011 | Past |
| Pramod Abcsdd | Additional Director | 22 Aug 2023 | Past |
| Pramod Abcsdd | Director | 30 Apr 2008 | Past |
| Pramod Abcsdd | Director | 11 Aug 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Genome International India Private Limited, for the financial year ended 2018, experienced modest growth in revenue, with a 6.48% increase. The company also saw a substantial fall in profitability, with a 98.02% decrease in profit. The company's net worth moved up by a moderate rise of 1.08%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2018, Genome International India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Genome International India has a workforce of 30 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Genome International India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Genome International India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Genome International India Private Limited last Annual general meeting of members was held on 31 Dec 2024 as per latest MCA records. was recorded as a recent event.
The activity Genome International India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai. was completed.
The activity Abarajeetha Rajendran was appointed as a Director was appointed as a Director on 09 Aug 2023 & has been associated with this company since 2 years 3 months . was completed.
The activity Periannan Senapathy was appointed as a Director was appointed as a Director on 09 Jul 2004 & has been associated with this company since 21 years 4 months . was completed.
Genome International India Private Limited was registered on 09 Jul 2004 with Roc Chennai & aged 21 years 4 months as per MCA records. was recorded as a recent event.
The CIN of Genome International India Private Limited is U73100TN2004PTC053684.
Genome International India Private Limited is headquartered at 383, I Cross Street, Nehru Nagar Old Mahabalipuram Road, Kottivakkam, Chennai, Tamil Nadu, 600096.
Genome International India Private Limited was incorporated on 09 July 2004.
The current directors of Genome International India Private Limited are
The primary industry of Genome International India Private Limited is Information Technology.
Genome International India Private Limited is unlisted.
The authorized capital of Genome International India Private Limited is ₹2.00 Cr, and the paid-up capital is ₹0.10 M.
The compliance status of Genome International India Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX